Key management personal of this now 0.012 cent per share valued company receive very reasonable remuneration (see extract below) where their sole objective and fiduciary duty is to act in the best interests of shareholders - share price is probably one of the most important indicators as to whether value is being created for shareholders.
I see many posts on operational success (yes there has been success) as well as the company making references to 3 pillars, yet i struggle to see how if any shareholder value has or is being created.
with the share price in continued decline , buy back opportunities at face value being missed by their partner, CPS , my 3 questions to mgmt are as follows :
1 why do you not back the company you represent and buy shares on market which are heading to 12 month lows ?
2 with the benefit of hindsight did you you get the buyback strategy wrong ?
3 do you have the capability and corporate intellect to successfully manage this company and actually deliver shareholder value ?
i was going to post these questions on the investor hub - but from what i hear questions raised by this method don't always get answered
share price performance - $0.012 @ 7/7/23
extract from 2022 Annual report
# be interesting to understand how much rem is paid to other mgmt such as GL ?
- Forums
- ASX - By Stock
- Ann: Update - Notification of buy-back - BRK
Key management personal of this now 0.012 cent per share valued...
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRK (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
-0.001(3.70%) |
Mkt cap ! $61.93M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.3¢ | $11.38K | 867.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 21633227 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 11192745 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 19633227 | 0.013 |
16 | 8040664 | 0.012 |
7 | 7243638 | 0.011 |
8 | 3900009 | 0.010 |
7 | 3170014 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 11192745 | 15 |
0.015 | 10254901 | 18 |
0.016 | 6888713 | 18 |
0.017 | 8285593 | 9 |
0.018 | 2434444 | 6 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
1.3¢ |
  |
Change
-0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
1.3¢ | 1.4¢ | 1.3¢ | 2880689 | ||
Last updated 15.55pm 06/05/2024 ? |
Featured News
BRK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online